| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
1.132 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
RYR2 |
RYR2: Ryanodine receptor 2 |
1.132 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
| ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
1.132 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.132 |
Evidence |
|
| EDA |
IPI00023765 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
| ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.132 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
1.132 |
Evidence |
|
| RPS10 |
RPS10: 40S ribosomal protein S10 |
CASP8 |
CASP8, MCH5: Caspase-8 precursor |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
MC4R |
MC4R: Melanocortin receptor 4 |
1.132 |
Evidence |
|
| SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
1.132 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 2 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
| AGT |
AGT, SERPINA8: Angiotensinogen precursor |
F11 |
F11: Coagulation factor XI precursor |
1.132 |
Evidence |
|
| GNAS |
GNAS, GNAS1, GSP: Guanine nucleotide-binding protein G(s) subunit alpha isoforms |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
1.132 |
Evidence |
|
| DRD2 |
DRD2: D(2) dopamine receptor |
GNA15 |
GNA15, GNA16: Guanine nucleotide-binding protein alpha-15 subunit |
1.132 |
Evidence |
|
| MATK |
MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
1.132 |
Evidence |
|
| F11 |
F11: Coagulation factor XI precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
1.132 |
Evidence |
|
| GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
PTAFR |
PTAFR, PAFR: Platelet-activating factor receptor |
1.132 |
Evidence |
|
| TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
1.132 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.132 |
Evidence |
|
| C3AR1 |
C3AR1, AZ3B, C3R1, HNFAG09: C3a anaphylatoxin chemotactic receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
| AZGP1 |
AZGP1, tcag7.638: Alpha-2-glycoprotein 1, zinc-binding |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
1.132 |
Evidence |
|
| NCK2 |
NCK2: Cytoplasmic protein NCK2 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
| MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
1.132 |
Evidence |
|
| IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
THPO |
THPO, MGDF: Thrombopoietin precursor |
1.132 |
Evidence |
|